Literature DB >> 30206011

Calculation Algorithm Reduces Protamine Doses Without Increasing Blood Loss or the Transfusion Rate in Cardiac Surgery: Results of a Randomized Controlled Trial.

Gunilla Kjellberg1, Manne Holm2, Thomas Fux3, Gabriella Lindvall3, Jan van der Linden3.   

Abstract

OBJECTIVES: The aim of the study was to investigate whether the HeProCalc algorithm affects heparin and protamine dosage, postoperative blood loss, and transfusion rate.
DESIGN: Randomized controlled trial.
SETTING: University hospital. PARTICIPANTS: The study comprised 210 cardiac surgery patients undergoing cardiac surgery with cardiopulmonary bypass. Twenty patients were excluded because of re-exploration for localized surgical bleeding (n = 9), violation of protocol (n = 2), aprotinin use (n = 3 and nadir body temperature <32°C (n = 6).
INTERVENTIONS: Study participants were randomly assigned to either traditional heparin and protamine dosage based on body weight only (control group) or dosage based on the HeProCalc algorithm (intervention group).
MEASUREMENTS AND MAIN RESULTS: The initial median heparin dose was 32,500 IU (interquartile range [IQR] 30,000-35,000) in the intervention group compared with 35,000 IU (IQR 30,000-37,500) (p = 0.025) in the control group. The total heparin dose in the intervention group was 40,000 IU (IQR 32,500-47,500) compared with 42,500 IU (IQR 35,000-50,000) in the control group (p = 0.685). The total protamine dose was 210 mg (IQR 190-240) in the intervention group compared with 350 mg (IQR 300-380) (p < 0.001) in the control group. The ratio of total protamine to initial dose of heparin in the intervention group was 0.62 compared with 1.0 (p < 0.001). The amount of chest tube bleeding after 12 postoperative hours was 320 mL (IQR 250-460) in the intervention group compared with 350 mL (IQR 250-450) (p = 0.754) in the control group. Neither the transfusion rate nor postoperative blood loss differed significantly between the 2 groups.
CONCLUSION: Use of the HeProCalc algorithm reduced protamine dosage and the protamine/heparin ratio after cardiopulmonary bypass compared with conventional dosage based on weight without significant effect on postoperative blood loss or the transfusion rate.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cardiac surgery; cardiopulmonary bypass; coagulation; heparin; protamine; surgical blood loss

Mesh:

Substances:

Year:  2018        PMID: 30206011     DOI: 10.1053/j.jvca.2018.07.044

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  2 in total

1.  Mesenchymal stem cell (MSc) secretome: A possible therapeutic strategy for intensive-care COVID-19 patients.

Authors:  Elenice Deffune; Aruã Prudenciatti; Andrei Moroz
Journal:  Med Hypotheses       Date:  2020-04-25       Impact factor: 1.538

Review 2.  Stem cell-derived biofactors fight against coronavirus infection.

Authors:  Mohammadreza Ardalan; Leila Chodari; Sepideh Zununi Vahed; Seyed Mahdi Hosseiniyan Khatibi; Aziz Eftekhari; Soodabeh Davaran; Magali Cucchiarini; Leila Roshangar; Elham Ahmadian
Journal:  World J Stem Cells       Date:  2021-12-26       Impact factor: 5.326

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.